Development
HCA Healthcare, Inc.
HCA
$376.86
$4.411.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 17.30B | 16.21B | 15.86B | 15.59B | 15.50B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.30B | 16.21B | 15.86B | 15.59B | 15.50B |
| Cost of Revenue | 10.15B | 9.97B | 9.76B | 9.51B | 9.48B |
| Gross Profit | 7.15B | 6.24B | 6.11B | 6.08B | 6.01B |
| SG&A Expenses | 994.00M | -- | -- | -- | 976.00M |
| Depreciation & Amortization | 789.00M | 769.00M | 763.00M | 756.00M | 750.00M |
| Other Operating Expenses | 2.57B | 3.38B | 3.04B | 2.89B | 1.87B |
| Total Operating Expenses | 14.50B | 14.12B | 13.56B | 13.16B | 13.08B |
| Operating Income | 2.80B | 2.09B | 2.30B | 2.43B | 2.41B |
| Income Before Tax | 2.35B | 1.63B | 1.81B | 1.92B | 3.30B |
| Income Tax Expenses | 484.00M | 355.00M | 397.00M | 379.00M | 656.00M |
| Earnings from Continuing Operations | 1.86B | 1.28B | 1.41B | 1.54B | 2.65B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -254.00M | -196.00M | -219.00M | -180.00M | -565.00M |
| Net Income | 1.61B | 1.08B | 1.19B | 1.36B | 2.08B |
| EBIT | 2.80B | 2.09B | 2.30B | 2.43B | 2.41B |
| EBITDA | 3.59B | 2.86B | 3.06B | 3.19B | 3.16B |
| EPS Basic | 5.93 | 3.98 | 4.35 | 4.92 | 7.28 |
| Normalized Basic EPS | 4.45 | 3.03 | 3.32 | 3.72 | 2.35 |
| EPS Diluted | 5.93 | 3.91 | 4.29 | 4.85 | 7.28 |
| Normalized Diluted EPS | 4.45 | 2.98 | 3.27 | 3.67 | 2.35 |
| Average Basic Shares Outstanding | 271.19M | 271.17M | 274.49M | 276.91M | 285.66M |
| Average Diluted Shares Outstanding | 271.19M | 275.42M | 278.20M | 280.96M | 285.66M |
| Dividend Per Share | 0.60 | 0.60 | 0.60 | 0.60 | 0.56 |
| Payout Ratio | 9.96% | 15.01% | 13.75% | 12.84% | 7.50% |